Records 1 - 17 (of 17 Records)
|Query Trace: Recurrence and meta-analysis and BRAF[original query]|
| BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.
Medicine 2012 Aug .
Tufano RP, Teixeira GV, Bishop J, Carson KA, Xing M
| The prognostic significance of the BRAF V600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry.
Pathology 2013 Dec 45 (7): 637-44.
McKelvie Penelope A, Chan Fiona, Yu Yong, Waring Paul, Gresshoff Irma, Farrell Stephen, Williams Richard
| [Association of BRAF(V) 600E mutation with clinical pathological features in papillary thyroid carcinoma: meta-analysis].
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 2014 Sep 49 (9): 759-64.
Yan Kangkang, Lin Xuejun, Li Shuang, Bao Honghong, Zhao Longyu, Liu X
| The association between BRAF (V600E) mutation and pathological features in PTC.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2014 Nov 271 (11): 3041-52.
Liu Xin, Yan Kangkang, Lin Xuejun, Zhao Longyu, An Wenxiu, Wang Chunpeng, Liu Xiaodo
| BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis.
Thyroid : official journal of the American Thyroid Association 2015 Dec .
Chen Yufei, Sadow Peter M, Suh Hyunsuk, Lee Kyu Eun, Choi June Young, Suh Yong Joon, Wang Tracy S, Lubitz Carrie Cunningh
| Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.
World journal of surgical oncology 2016 14 (1): 241.
Liu Chunping, Chen Tianwen, Liu Zemi
| The BRAF V600E mutation predicts poor survival outcome in patients with papillary thyroid carcinoma: a meta analysis.
International journal of clinical and experimental medicine 2015 8 (12): 22246-53.
Li Jianhua, Zhang Shuijun, Zheng Shouhua, Zhang Danhua, Qiu Xingua
| Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2016 Feb 38 (2): 763-776.
Zhang Qing, Liu Shao-Zheng, Zhang Qing, Guan Yan-Xing, Chen Qing-Jie, Zhu Qin-Y
| Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.
OncoTargets and therapy 2016 9 6965-6976.
Su Xingyun, Jiang Xiaoxia, Wang Weibin, Wang Haiyong, Xu Xin, Lin Aihui, Teng Xiaodong, Wu Huiling, Teng Liso
| TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis.
Scientific reports 2016 Nov 6 36990.
Liu Chunping, Liu Zeming, Chen Tianwen, Zeng Wen, Guo Yawen, Huang T
| Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.
Critical reviews in oncology/hematology 2016 Jan .
Passiglia Francesco, Bronte Giuseppe, Bazan Viviana, Galvano Antonio, Vincenzi Bruno, Russo Anton
| THE RELATIONSHIP OF BRAF MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017 11 24 (1): 21-26.
Santhanam Prasanna, Khthir Rodhan, Solnes Lilja B, Ladenson Paul
| Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Diagnostic pathology 2019 Jul 14 (1): 74.
Huang Meiling, Yan Changjiao, Xiao Jingjing, Wang Ting, Ling R
| The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Frontiers in oncology 2020 10 540238.
Zhao Ling, Wang Lin, Jia Xiaomeng, Hu Xiaodong, Pang Ping, Zhao Sitong, Wang Yajing, Wang Jing, Zhang Yingshi, Lyu Zhaoh
| Hashimoto's Thyroiditis: A "Double-Edged Sword" in Thyroid Carcinoma.
Frontiers in endocrinology 2022 3 13 801925.
Xu Jiangyue, Ding Ke, Mu Lan, Huang Jiangsheng, Ye Fei, Peng Yu, Guo Can, Ren Chuto
| BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis.
Cancers 2022 11 14 (22): .
Mamat Yusof Mohd Nazzary, Ch'ng Ewe Seng, Radhiah Abdul Rahman Naw
| Differential Profile of Primary and Recurrent Ameloblastomas Among Afro-descendants and Non-Afro-descendants-a Systematic Review.
Journal of racial and ethnic health disparities 2023 1 .
Patel Parth, Effiom Olajumoke A, Akinshipo Abdul-Warith O, Akintoye Sunday